Nucleoside analogue

Results: 25



#Item
1DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATE

DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATE

Add to Reading List

Source URL: bch.nus.edu.sg

Language: English - Date: 2015-08-20 23:15:40
2Abstract  Conjugation of anticancer drugs to biocompatible water soluble polymers is an attractive approach to improve the drug’s blood solubility and stability, tumour targeting properties and antitumour efficiency, w

Abstract Conjugation of anticancer drugs to biocompatible water soluble polymers is an attractive approach to improve the drug’s blood solubility and stability, tumour targeting properties and antitumour efficiency, w

Add to Reading List

Source URL: dspace.fsktm.um.edu.my

Language: English - Date: 2009-12-31 01:50:07
32005  Bowden, S, R. McCaw, P. A. White, J. N. Crofts and C. K. Aitken[removed]Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. Journal of Viral Hepatitis. 12:[removed]Bull, R. A., G.

2005 Bowden, S, R. McCaw, P. A. White, J. N. Crofts and C. K. Aitken[removed]Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. Journal of Viral Hepatitis. 12:[removed]Bull, R. A., G.

Add to Reading List

Source URL: ach2.publishpath.com

Language: English - Date: 2012-09-03 01:18:09
4Chapter 10 Final Discussion, Future Perspective and Conclusion 10.1 Final discussion  To investigate the outcome of applying the polymer drug conjugation strategy to

Chapter 10 Final Discussion, Future Perspective and Conclusion 10.1 Final discussion To investigate the outcome of applying the polymer drug conjugation strategy to

Add to Reading List

Source URL: dspace.fsktm.um.edu.my

Language: English - Date: 2009-12-31 01:50:07
5Microsoft Word[removed]Peripheral Neuropathy amend bp.doc

Microsoft Word[removed]Peripheral Neuropathy amend bp.doc

Add to Reading List

Source URL: www.rma.gov.au

Language: English - Date: 2014-05-06 01:28:00
6Microsoft Word[removed]Peripheral Neuropathy amend rh.doc

Microsoft Word[removed]Peripheral Neuropathy amend rh.doc

Add to Reading List

Source URL: www.rma.gov.au

Language: English - Date: 2014-05-06 01:27:59
7ZERIT® (stavudine) ZERIT® (stavudine) Capsules ZERIT® (stavudine) for Oral Solution (Patient Information Leaflet Included)  WARNING

ZERIT® (stavudine) ZERIT® (stavudine) Capsules ZERIT® (stavudine) for Oral Solution (Patient Information Leaflet Included) WARNING

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:08:07
8HIGHLIGHTS OF PRESCRIBING INFORMATION  ----------------------DOSAGE FORMS AND STRENGTHS--------------------• Tablet: 600-mg tablets supplied in 30-count bottles[removed]These highlights do not include all the informati

HIGHLIGHTS OF PRESCRIBING INFORMATION ----------------------DOSAGE FORMS AND STRENGTHS--------------------• Tablet: 600-mg tablets supplied in 30-count bottles[removed]These highlights do not include all the informati

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:51:21
9HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BARACLUDE safely and effectively. See full prescribing information for BARACLUDE. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BARACLUDE safely and effectively. See full prescribing information for BARACLUDE. ®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-07-24 02:07:51
10PID comments (clarifax in January 2006)

PID comments (clarifax in January 2006)

Add to Reading List

Source URL: www.bmscanada.ca

Language: English - Date: 2013-12-10 10:20:22